Document is current
Any future updates will be listed below
-
Authors
Aldossari, Khaled K.
AlRuthia, Yazed
Amir, Ashraf
Alshurem, Mohammed
Elbadawi, Hussein
Kaki, Abdullah
-
Funding
Funding for this research was provided by:
Viatris
- License Information
-
More Information
Article History
Received: 14 March 2025
Accepted: 9 May 2025
First Online: 2 June 2025
Declarations
:
: Khaled Aldossari has received payment for speaker and instructor from Novo Nordisk, AstraZeneca, and Sanofi; Yazed AlRuthia has received payment for participating in speaker bureaus at multiple conferences, addressing various disease states and their management from a health economist and outcomes research perspective, supported by Hikma Pharmaceuticals, Boehringer Ingelheim, Merck Serono, and Sandoz; Ashraf Amir and Mohammed Alshurem have no conflict of interest to declare; Hussein Elbadawi has received payments for speaker bureau activities from Sanofi, Novo Nordisk, Boehringer Ingelheim, and Ei Lilly; Abdullah Kaki has received payment for speaker bureau engagements related to educational activities aimed at enhancing practitioners knowledge in pain management, sponsored by Pfizer and AbbVie.
: This review article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
